Cargando…
MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT
BACKGROUND: Aberrant hyperactivation of epithelial proliferation, AKT signaling, and association with unopposed estrogen (E2) exposure is the most common endometrial cancer dysfunction. In the normal uterus, progesterone (P4) inhibits proliferation by coordinating stromal-epithelial cross-talk, whic...
Autores principales: | Yoo, Jung-Yoon, Kang, Hee-Bum, Broaddus, Russell R., Risinger, John I., Choi, Kyung-Chul, Kim, Tae Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975686/ https://www.ncbi.nlm.nih.gov/pubmed/29843645 http://dx.doi.org/10.1186/s12885-018-4502-7 |
Ejemplares similares
-
MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer
por: Jeong, Olivia, et al.
Publicado: (2022) -
MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial
cells
por: Yoo, Jung-Yoon, et al.
Publicado: (2017) -
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression
por: Kim, Tae Hoon, et al.
Publicado: (2010) -
Loss of MIG-6 results in endometrial progesterone resistance via ERBB2
por: Yoo, Jung-Yoon, et al.
Publicado: (2022) -
An immune competent orthotopic model of endometrial cancer with metastasis
por: Fedorko, Alyssa M., et al.
Publicado: (2020)